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Expression of 5-Lipoxygenase and 5-Lipoxygenase-Activating Protein in
Immune Cells
Huan Ma, Liheng Guo, Shiyu Ma, Xin Huang, Yanfen Chen,
Minzhou Zhang
Guangdong Provincial Hospital of Traditional Chinese Medicine
OBJECTIVES Arachidonic acid (AA), an omega-6 (n-6) fatty acid, can
be converted to inﬂammatory leukotrienes (LTs) by 5-lipoxygenase (5-
LO), which is activated by 5-lipoxygenase-activing protein (FLAP) and
then lead to the expression of LTB4, which play a role in coronary
heart disease (CHD).omega-3 (n-3) fatty acids are the metabolic
counterparts to n-6 fatty acids and have anti-inﬂammatory effects.
Thus, the tissue ratio of n-6/n-3 fatty acids may inﬂuence LT pro-
duction. However, whether alteration of tissue n-6/n-3 fatty acid ratio
has an effect on 5-LO and FLAP expression is not well known. The fat-
1 transgenic mouse, expressing an n-3 fatty acid desaturase, is capable
of endogenously converting n-6 fatty acids to n-3 fatty acids, and
thereby has a tissue n-6/n-3 fatty acid ratio close to 1:1. The aim of the
study was to compare 5-LO and FLAP expression status in immune
cells between fat-1 transgenic mice and wild type (WT) littermates.
METHODS Immune cells from fat-1 transgenic mice (n¼5) and WT
mice (n¼5) were harvested from the spleen and cultured for 24h.
Mononuclear cells were also isolated from the blood. Cellular n-6/n-3
fatty acid proﬁles were analyzed using gas chromatography. The
mRNA and protein expressions of 5-LO and FLAP in the cells were
evaluated using real time RT-PCR and immunoblot (WB) assays,
respectively. the expression of LTB4 level was assessed by Elisa assay.
RESULTS He fat-1 transgenic mice showed a lower ratio of n-6/n-3
fatty acids than WT mice in both splenocytes and blood monocytes
(AA: 4.530.10 VS 2.160.09; EPA: 0.130.07 VS 0.360.15; DHA:
0.490.14 VS 2.170.76; Total u-3: 0.680.29 VS 2.660.70; u-6/u-3:
9.494.70 VS 1.320.36). The mRNA expressions of 5-LO and FLAP
were signiﬁcantly lower in the cells of fat-1 mice than in those of WT
mice. Accordingly, the protein levels of 5-LO and FLAP were also
markedly lower in fat-1 mice than in WT mice. The LTB4 level was also
lower in fat-1 mice than WT mice.
CONCLUSIONS Our ﬁndings demonstrate that a decreased tissue n-6/
n-3 fatty acid ratio reduces 5-LO and FLAP expression. This study
suggests a role for tissue n-6/n-3 fatty acid ratio in the 5-LO pathway
of AA metabolism in immune cells, and a new mechanism for the anti-
inﬂammatory effect of n-3 fatty acids, omega-3 fatty acid may play a
role in the prevention of CHD.
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A prescription of Jiashen reduces postinfarct left ventricular remodeling
via inhibition of TGF-b/Smads signaling pathway
Yuan Gao, Shiyang Xie, Youping Wang, Bin Li, Xiaoli Nan,
Weihong Liu, Mingjun Zhu
First Afﬁliated Hospital, Henan University of Traditional Chinese
Medicine
OBJECTIVES To explore the mechanisms underlying A prescription of
Jiashen(PJS)-mediated cardioprotection, we determined whether PJS
reduces early left ventricular remodeling via inhibiting TGF-b/Smads
signaling pathway in a rat model of myocardial infarction(MI).
METHODS Male Sprague-Dawley rats were subjected to sham-
operation orMI by ligating the left anterior descending coronary artery.
The rats withMI were treated with vehicle, PJS at the dose of 3 g/kg/day
and 6 g/kg/day, or losartan at the dose of 10mg/kg/day 24h afterMI. The
rats in the vehicle group and the sham-operation group were intra-
gastrically given at the same dosage of normal saline. One weeks later,
we determined the effects of PJS and losartan on cardiac function, and
the distribution and level of collagen using echocardiography, Mas-
son’s trichrome stain and hydroxyproline assay, respectively. The
myocardial expression of TGF-b/Smads signaling pathway was deter-
mined by the use of Western blot.
RESULTS Compared to MIþvehicle rats, PJS at the dose of 6g/kg/day
reduced the increases in left ventricular end-diastolic dimension
(0.820.04 vs. 0.660.04 cm, P<0.05) and left ventricular end-systolic
dimension (0.610.03 vs. 0.400.04 cm, P<0.05), and the decreases in
ejection fraction(55.264.60% vs. 70.755.61%, P<0.05) and fractional
shortening (25.682.91% vs. 36.69 3.94%, P<0.05) at week 1 after MI.
In addition, treatment with PJS at the dose of 6 g/kg/day inhibited the
increased levels of collagen (10.840.79vs. 16.751.53 pg/mg protein,
P<0.05) and the expression of transforming growth factor-b1(TGF-b1),
phosphorylated Smad 2(p-Smad 2), and phosphorylated Smad
3(p-Smad 3) compared to MIþvehicle rats at week 1 after MI (TGF-b1:1.060.01 vs. 1.39 0.01%GAPDH arbitrary units; p-Smad 2: 1.520.00
vs. 2.06 0.03% GAPDH arbitrary units; p-Smad 3: 0.500.00 vs.
1.050.01% GAPDH arbitrary units, P<0.05). Losartan treatment has
the similar results with PJS at the dose of 6 g/kg/day.
CONCLUSIONS Our data demonstrated that PJS treatment improved
cardiac function, and reduced myocardial ﬁbrosis at the early stage of
MI. The results were associated with the inhibition of the expression
of TGF-b/Smads signaling expression. Our results suggest that PJS
may improve left ventricular remodeling possibly via attenuating
TGF-b/Smads signaling pathway in the early period of MI.
[This work was supported by a grant from the National Natural
Science Foundation of China (No. 81173410)].
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Fufangxueshuantong ameliorates diabetic cardiomyopathy in rats by
attenuating cardic and metabolic dysfunction
Jing Han, Yan Wu, Tiantian Lv, Hongliang Wang, Gaimei Hao, Jie He,
Wei Wang
Beijing University of Chinese Medicine
OBJECTIVES Diabetic cardiomyopathy (DCM) can cause diastolic and
systolic dysfunction damage, resulting in myocardial ischemia and heart
failure. Fufangxueshuantong (FXST), which is composed of Panax noto-
ginseng, Salvia miltiorrhiza, Astragalus membranaceus and Scrophularia
ningpoensis, has been used for the treatment of angina pectoris and dia-
betic retinopathy for years. However, whether FXST has an effect on DCM
is unknown. Metabolic dysfunction occurs in hearts and contributes to
DCM. Adenosine monophosphate-activated protein kinase (AMPK),
peroxisome proliferator activated receptorg coactivator 1 (PGC1a) and si-
lent information regulator 1(sirt1) signaling pathways sense the metabolic
demands and impinge on expression of genes encoding for metabolic
enzymes (citrate synthase(CS), etc). So the present study aims to demon-
strate that whether FXST treatment can ameliorate cardiac function in
diabetic rats and to illustrate its effect on energy metabolic mechanism.
METHODS SD rats were randomly divided into 3 groups: normal
group, diabetic group, diabeticþFXST group. 20 weeks after strepto-
zocin induction, FXST or water was administered for 16 weeks. Car-
diac dimensions and function were determined by echocardiography.
Left ventricular internal diameter during diastole (LVIDd) and systole
(LVIDs) were assessed in M-mode, and ejection fraction (EF), frac-
tional shortening (FS) and left ventricular mass (LV mass) were
calculated with the M-mode measurements. Doppler echocardiogra-
phy was used to measure IVRT (Isovolumic relaxation time) and E/A
(Ratio of peak early to late transmitral blood ﬂow velocities). After
echocardiographic detection, the indicators of energy metabolism (CS,
AMPK, PGC1a, sirt1) in hearts were detected through PCR.
RESULTS Echocardiography revealed that in the diabetic group, a
decrease in E/A and an increase in IVRT were observed in the rats (vs.
normal group). Following treatment with FXST in the diabetic rats, E/A
was found to be upregulated, (vs. diabetic group). In the diabetic group,
a decrease in EF, FS, LV mass and an increase in LVIDd, LVIDs were
observed in the rats (vs. normal group). Following treatment with FXST
in the diabetic rats, EF and FS were found to be upregulated, while
LVIDd and LVIDs were markedly decreased (vs. diabetic group).
Real time PCR analysis revealed decreased content of PGC1a, sirt1
and increased levels of CS, AMPK in the diabetic group when
compared with the normal group. However, increased levels of (CS,
AMPK, PGC1a, sirt1) were observed in the FXST-treated group when
compared with the diabetic group.
CONCLUSIONS Our study demonstrated that diabetes induced diabetic
cardiomyopathy, characterized by both diastolic and systolic dysfunc-
tion and metabolic dysfunction in heart. And FXST protected DCM via
attenuating cardiac function. In addition, therapeutic FXST administra-
tion can promote gene levels of energy metabolism. These ﬁndings pro-
vide evidence as to the cardiac protective efﬁcacy of FXST to DCM.
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Cardioprotective effect of propofol against oxygen glucose deprivation
and reperfusion injury in H9c2 cells
Dandan Zhao,1 Jiang Hong1,2
1Shanghai General Hospital, Shanghai Jiao Tong University; 2School of
Pharmacy, Shanghai Jiao Tong University
OBJECTIVES The intravenous anesthetic propofol is reported to be a
cardioprotective agent against ischemic-reperfusion injury in the
heart. However, the regulatory mechanism still remains unclear.
METHODS In the study, we used H9c2 cell line under condition of
oxygen glucose deprivation (OGD) followed by reperfusion (OGD/R) to
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(5-20 mM) were added to the cell cultures before and during the OGD/R
phases to investigate the underlying mechanism.
RESULTS Our data showed that OGD/R decreased cell viability,
increased lactate dehydrogenase leakage, reactive oxygen species and
malondialdehydeproduction inH9c2 cells, all ofwhichwere signiﬁcantly
reversed by propofol. Moreover, we found that propofol increased both
the activities and protein expressions of superoxide dismutase and
catalase. In addition, propofol increased FoxO1 expression in a dose-
dependent manner and inhibited p-AMPK formation signiﬁcantly.
CONCLUSIONS These results indicate that the propofol might exert its
antioxidative effect through FoxO1 in H9c2 cells, and it has a potential
therapeutic effect on cardiac disorders involved in oxidative stress.
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Echocardiography-guided percutaneous laser ablation of canine
ventricular septum
Liwen Liu
Department of Ultrasound, Xijing Hospital, Fourth Military Medical
University
OBJECTIVES Currently surgical myectomy and ethanol ablation are two
established interventions for relieving the left ventricular outﬂow
obstruction in hypertrophic cardiomyopathy (HCM) patients. The limi-
tations in safety and efﬁcacy in these interventions call for minimally
invasive, potentially safer andmore efﬁcacious approach. The aim of this
study is to validate the feasibility of echocardiography-guided percuta-
neous per-ventricular laser ablation of the canine ventricular septum.
METHODS Six domestic dogs were chosen for the study. Laser (Nd:
YAG, 800-1064 nm-wavelength, 300mm-diameter ﬁber, Echo Laser
X4, Elesta S.R.L., Italy) was used. The laser passed through a needle
(21G, PTC, ECOCHIBA, Italy) that inserted from the right ventricle into
the targeted septum under the guidance of the echocardiography via a
percutaneous route. Laser ablation was performed as follows: 1 W
laser for 3 and 5 min at 180 and 300 J, respectively. Echocardiography,
serology examination and pathology were performed to assess the
results of laser ablation.
RESULTS There was no death or major complication, i.e. tamponade,
pericardial effusion or ventricular ﬁbrillation. The real-time echocar-
diography monitor of M-mode, 2D (LVEF), PW Doppler and TDI pre-
sented no signiﬁcant variation before and after the laser ablation.
Contrast echocardiography conﬁrmed the perfusion defects in the
ablated septal regions. The laser ablated areas were well demarcated
on pathology examination and the diameters of the ablated region
were (mm) 4.42  0.57 and 5.28  0.83 for 3- and 5-minute ablation,
respectively. Pre- and post-ablation cardiac enzymes (IU/L) were: AST:
39.17  11.23 vs 183  101.07 (p¼0.02), LDH: 71  33.89 vs 253.33 
179.63 (p¼0.07), CK: 468.17 192.42 vs 2775.17  1309.35 (p¼0.007),
and CK-MB: 174.33  113.34 vs 897.17  486.84 (p¼0.03). Microscop-
ically, the ablated myocardium showed contracted coagulative
changes. Nuclei disappeared and a zone of vacuoles was formed with
red blood cells inﬁltrating into the widened intercellular space.
CONCLUSIONS Our research showed that percutaneous laser ablation
of the septum is feasible, potentially safe and efﬁcacious and may
become a viable alternative solution to septum ablation.
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Protective Effects of Dihydromyricetin and Myricetin against Myocardial
Ischemia/Reperfusion Injury In Vivo and In Vitro
Yong Ye,1 Xianhong OU,2 Qiujie Huang,3 Huagang Liu,1
Yonghong Liang,1 Yefei Yuan,4 Yunfei Song,5 Xiaorong Zeng2
1College of pharmacy, Guangxi Medical University, Nanning 530021,
Guangxi, China; 2The Key Laboratory of Medical Electrophysiology,
Ministry of Education of China, and the Institute of Cardiovascular
Research, Luzhou Medical College; 3College of pharmacy, Guangxi
Traditional Chinese Medical University, Guangxi Nanning 530001,
China; 4College of pharmacy, Luzhou Medical College, Luzhou 646000,
Sichuan, China; 5Postdoctoral R&D Workstations, Guilin Layn Natural
Ingredients Corp, Guilin 541100, China
OBJECTIVES The aims of this study were to determine whether Myr
or DMY exert any cardioprotective effect against I/R injury and
investigate the responsible underlying mechanisms.
METHODS The study utilized an in vitro rat cardiomyocyteH9C2model
of hypoxia/reoxygenation (H/R) injury and an in vivo rat model of MI/R
injury. H/R injury was determined by Cell Counting Kit-8 (CCK-8) assay
and lactate dehydrogenase (LDH) leakage assay. In the in vivoexperiment, histopathology staining was examined. Additionally, car-
diac injury markers maleic dialdehyde (MDA), superoxide dismutase
(SOD), glutathione reductase (GSH), myeloperoxidase (MPO), nitric-
oxide synthase (NOS), Ca2þ-Mg2þ-ATPase and Naþ-Kþ-ATPase were
detected. TUNEL assay and caspases activation assays were used to
investigate apoptosis. To assess levels of apoptotic regulators, immu-
nohistochemical staining and real-time PCR were employed.
RESULTS Both Myr and DMY have no cytotoxic effect at the concen-
trations of 0.5-80 mMMyr or 10-200 mMDMY for 24 hours in H9C2 cells.
after being subject to H/R, cellular viability was signiﬁcantly reduced in
the H/R group (P < 0.01 compared to control), and LDH leakage was
highly increased compared to control (P < 0.01). DMY or Myr post-
conditioning signiﬁcantly increased cell viability compared with the H/
R group. DMY (25, 50 and 100 mM) or Myr (20 and 50 mM) markedly
reducedH/R-induced cell death and decreased LDH leakage (P<0.05 or
P < 0.01). These results indicate that DMY and Myr signiﬁcantly pre-
served cellular viability post-H/R injury in a dose-dependent manner.
Both DMY andMyr protectedmyocardium against I/R (or H/R) injury by
increasing NOS, SOD, GSH and ATPases activity, decreasing MDA con-
tent and MPO activity at different degrees and attenuating histopa-
thology injury. Meanwhile, DMY and Myr inhibited the cardiomyocyte
apoptosis. The level of Bcl-2 protein and mRNA were restored to the
normal level by DMY or Myr pharmacological postconditioning. In
contrast, the Bax protein level andmRNA level were markedly reduced
by DMY and Myr pharmacological postconditioning.
CONCLUSIONS DMY andMyr pharmacological postconditioning could
protect againstmyocardial I/R injury in both in vivo and in vitromodels,
which are related to apoptosis pathway and antioxidant activity.
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Role of calreticulin-induced mitochondrial damage in high glucose induced
apoptosis in myocardial cells
Rui Yan,1,2 Hu Shan,3 Lin Lin,1,2 Jiayu Diao,1,2 Ming Zhang,3 Yanhe Zhu,4
Wuhong Tan,4 Wei Jin1,2
1Department of Cardiology, Second Afﬁliated Hospital, Xi’an Jiaotong
University School of Medicine, Xi’an 710004, China; 2Department of
Endemic Disease, Second Afﬁliated Hospital, Xi’an Jiaotong University
School of Medicine, Xi’an 710004, China; 3Department of Respiratory
Medicine, Second Afﬁliated Hospital, Xi’an Jiaotong University School
of Medicine, Xi’an 710004, China; 4Key Laboratory of Environment and
Genes Related to Diseases of Ministry of Education, Key Laboratory of
Trace Elements and Endemic Disease of Ministry
OBJECTIVES To observe the effect of high glucose on the protein
expression of calreticulin (CRT) and its association with cell apoptosis
and mitochondrial dysfunction in the cardiomyocytes.
METHODS AC-16 cardiomyocytes were randomly divided into normal
glucose group, high glucose group, high glucoseþ CRT siRNA and
isotonic control group. The cell apoptotic rate, reactive oxygen species
(ROS), mitochondrial membrane potential level, respiratory enzyme
activities, and protein expression of CRT were observed.
RESULTS Compared with the cardiomyocytes in normal glucose
group, the apoptotic rate of cardiomyocytes and ROS production
increased in high glucose groups, accompanying with the decreases in
the mitochondrial membrane potential level and enzyme activities of
the respiratory chain. The protein expression of CRT was signiﬁcantly
increased in high glucose group. However, compared with high
glucose group, high glucoseþ CRT siRNA decreased the expression of
CRT and attenuated the damage of mitochondrion, but CRT siRNA did
not reduce the ROS level in cardiomyocytes.
CONCLUSIONS High glucose brought about CRT over-expression to
induce mitochondrial injury, which may be a reason of increasing
myocardial apoptosis.
GW26-e4818
The L-carnitine Ameliorates Pulmonary Arterial Hypertension by Improving
Energy Metabolism Dysfunction of Right Ventricular Failure
Yan Liu,1,2 Xiaojian Wang,2 Qianqian Liu,2 Yi Yan,2 Shuhui Yang,2
Suqi Li,2 Shenshen Huang,3 Zhicheng Jing2
1Department of Nuclear Medicine, The First Afﬁliated Hospital of
Zhengzhou University; 2Thrombosis Medicine Center, State Key
Laboratory of Cardiovascular Disease, FuWai Hospital, Peking Union
Medical College and Chinese Academy Medical S; 3Department of
respiration, The First Afﬁliated Hospital of Henan University of Science
and Technology
OBJECTIVES L-carnitine is indispensable for energy metabolism and
mitochondrial function in the myocardium. Although carnitine
